Ravid Straussman
object(WP_Post)#5023 (24) {
["ID"]=>
int(970)
["post_author"]=>
string(1) "3"
["post_date"]=>
string(19) "2018-12-05 11:39:21"
["post_date_gmt"]=>
string(19) "2018-12-05 11:39:21"
["post_content"]=>
string(18) "[flsSpeakersModal]"
["post_title"]=>
string(16) "Ravid Straussman"
["post_excerpt"]=>
string(0) ""
["post_status"]=>
string(7) "publish"
["comment_status"]=>
string(6) "closed"
["ping_status"]=>
string(6) "closed"
["post_password"]=>
string(0) ""
["post_name"]=>
string(16) "ravid-straussman"
["to_ping"]=>
string(0) ""
["pinged"]=>
string(0) ""
["post_modified"]=>
string(19) "2018-12-20 11:12:10"
["post_modified_gmt"]=>
string(19) "2018-12-20 11:12:10"
["post_content_filtered"]=>
string(0) ""
["post_parent"]=>
int(0)
["guid"]=>
string(64) "https://www.bcnmicrobiome.com/?post_type=fls-speakers&p=970"
["menu_order"]=>
int(0)
["post_type"]=>
string(12) "fls-speakers"
["post_mime_type"]=>
string(0) ""
["comment_count"]=>
string(1) "0"
["filter"]=>
string(3) "raw"
}
Straussman, Ravid
Weizmann Institute of Science. Rehovot, Israel.
Dr. Ravid Straussman completed a BSc at the Hebrew University Hadassah Medical School. He earned his MSc in Medical Biochemistry and then graduated the MD/PhD program of Hadassah Medical School followed by an MD internship. After completing a short post-doc training period at the lab of Dr. Howard Cedar he joined the lab of Dr. Todd Golub at the Broad Institute of Harvard and MIT for a second postdoc training period where he studied the effects of the tumor microenvironment on chemoresistance. At 2013 he joined the Weizmann Institute as a principal investigator. The Straussman lab studies different aspects of the tumor microenvironment and the tumor microbiome with a special focus on how non-cancer components in the tumor microenvironment can affect the response of cancer cells to cytotoxic, targeted and immune-mediated anti-cancer therapies.